CPRX

$0.00

(

0.00%

)
Quote details

stock

Catalyst Pharmaceuticals Inc

NASDAQ | CPRX

20.07

USD

$0.00

(

0.00%

)

At Close (As of Sep 8, 2025)

$2.48B

Market Cap

12.3

P/E Ratio

1.65

EPS

$26.58

52 Week High

$19.00

52 Week Low

HEALTHCARE

Sector

CPRX Chart

Recent Chart
Price Action

CPRX Technicals

Tags:

CPRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $423M
Total Revenue $492M
Cost Of Revenue $69M
Costof Goods And Services Sold $69M
Operating Income $195M
Selling General And Administrative $168M
Research And Development $13M
Operating Expenses $228M
Investment Income Net -
Net Interest Income $16M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $38M
Income Before Tax $216M
Income Tax Expense $52M
Interest And Debt Expense -
Net Income From Continuing Operations $164M
Comprehensive Income Net Of Tax -
Ebit $195M
Ebitda $233M
Net Income $164M

Revenue & Profitability

Earnings Performance

CPRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $851M
Total Current Assets $624M
Cash And Cash Equivalents At Carrying Value $518M
Cash And Short Term Investments $518M
Inventory $20M
Current Net Receivables $65M
Total Non Current Assets $228M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $157M
Intangible Assets Excluding Goodwill $157M
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments -
Other Current Assets $21M
Other Non Current Assets -
Total Liabilities $124M
Total Current Liabilities $121M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $402K
Total Non Current Liabilities $3.1M
Capital Lease Obligations $3.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.2M
Other Current Liabilities $103M
Other Non Current Liabilities $315K
Total Shareholder Equity $728M
Treasury Stock -
Retained Earnings $285M
Common Stock $121K
Common Stock Shares Outstanding $125M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $240M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $38M
Capital Expenditures $556K
Change In Receivables -
Change In Inventory -$4.7M
Profit Loss -
Cashflow From Investment -$556K
Cashflow From Financing $141M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$296K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $164M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $423M
Total Revenue $492M
Cost Of Revenue $69M
Costof Goods And Services Sold $69M
Operating Income $195M
Selling General And Administrative $168M
Research And Development $13M
Operating Expenses $228M
Investment Income Net -
Net Interest Income $16M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $38M
Income Before Tax $216M
Income Tax Expense $52M
Interest And Debt Expense -
Net Income From Continuing Operations $164M
Comprehensive Income Net Of Tax -
Ebit $195M
Ebitda $233M
Net Income $164M

CPRX News

CPRX Profile

Catalyst Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-0.80%
$18.47
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
YAAS
-21.16%
$0.08
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
RIG
+2.93%
$3.16
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.53%
$16.79
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
QBTS
+0.32%
$15.42
CRWV
+5.00%
$93.55
MULN
-17.38%
$0.14
ITUB
-0.70%
$7.05
DVLT
+1.69%
$0.31
NGD
+3.49%
$6.52
JD
+4.45%
$32.85
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-0.80%
$18.47
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
YAAS
-21.16%
$0.08
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
RIG
+2.93%
$3.16
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.53%
$16.79
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
QBTS
+0.32%
$15.42
CRWV
+5.00%
$93.55
MULN
-17.38%
$0.14
ITUB
-0.70%
$7.05
DVLT
+1.69%
$0.31
NGD
+3.49%
$6.52
JD
+4.45%
$32.85

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.